Statement on New Universal Flu Vaccine Development Grand Challenge

WASHINGTON, D.C. – April 27, 2018 – The new $12 million Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Development from the Bill & Melinda Gates Foundation and Lucy and Larry Page is an important and necessary step toward finding a game-changing solution to end the threat of flu, according to experts at the Sabin Vaccine Institute (Sabin), a leading advocate for expanding vaccine access and uptake across the world. This challenge invites researchers from any discipline to submit innovative ideas for safe, effective, affordable flu vaccines.
Last night, more than one hundred guests joined together to honor Dr. Paul Offit as the recipient of the 2018 Sabin Gold Medal. Colleagues, family, friends and peers gathered at the National Academy of Sciences building in Washington, D.C., to celebrate Dr. Offit’s contributions to immunization, including his achievements as the co-inventor of an oral rotavirus vaccine and his leadership as a vocal and dedicated advocate for immunization.
Every year, the Albert B. Sabin Gold Medal is given to a distinguished member of the public health community who has made extraordinary contributions in the field of vaccinology or a complementary field. This year's award will honor Dr. Paul Offit for his contributions as co-inventor of an oral rotavirus vaccine and his leadership as one of the United States’ most vocal and dedicated advocates for immunization.

Dr. Paul Offit Receives 2018 Albert B. Sabin Gold Medal

WASHINGTON, D.C. – April 24, 2018 – Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Paul Offit with the 2018 Albert B. Sabin Gold Medal. Sabin will recognize Dr. Offit for his contributions as co-inventor of an oral rotavirus vaccine and his leadership as one of the United States’ most vocal and dedicated advocates for immunization.

Dr. Ruth Nussenzweig died on April 1, 2018 at age 89. Dr. Nussenzweig was the 2008 recipient of the Sabin Gold Medal for her pioneering research that led to the development of the RTS,S malaria vaccine. Over a career that spanned nearly six decades, Dr.

WHO recommends use of first typhoid conjugate vaccine

Geneva, Switzerland – April 3, 2018 – The World Health Organization (WHO) recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries. This new policy will help ensure access to typhoid vaccination in communities most impacted by the disease, which is responsible for nearly 12 million infections and between 128,000 and 161,000 deaths a year.

For the 11th year in a row, the Sabin Vaccine Institute has received Charity Navigator's highest rating.

Dr. Albert Bruce Sabin, best known as the developer of the oral live virus polio vaccine, died 25 years ago. Over the course of a career that spanned nearly six decades, his discoveries and approaches to research shaped the modern world.

Pages